Mathematical Simulation of Transport Kinetics of Tumor-Imaging Radiopharmaceutical 99mTc-MIBI

The proposed model describes in a quality way the process of tumor-imaging radiopharmaceutical 99mTc-MIBI distribution with taking into account radiopharmaceutical accumulation, elimination, and radioactive decay. The dependencies of concentration versus the time are analyzed. The model can be easily tested by the concentration data of the radioactive pharmaceuticals in the blood measured at early time point and late time point of the scanning, and the obtained data can be used for determination of the washout rate coefficient which is one of the existing oncology diagnostics methods.

• Publication year

  2017

• Venue

  Comput. Math. Methods Medicine

• Publication date

  2017-06-15

• Fields of study

  Mathematics, Materials Science, Medicine, Computer Science

• Identifiers
  DOI 10.1155/2017/2414878PMID 28702073PMCID 5494117
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• LAPLACE TRANSFORM IN TRACER KINETIC MODELING

  2013cited by this paper
• 99mTc-MIBI Whole Body Scan: A Potentially Useful Technique for Evaluating Metabolic Bone Disease

  2013cited by this paper
• Evaluation of Cardiac Mitochondrial Function by a Nuclear Imaging Technique using Technetium-99m-MIBI Uptake Kinetics

  2013cited by this paper
• Imaging of multidrug resistance in cancer

  2011cited by this paper
• Mitochondrial morphology and cardiovascular disease.

  2010cited by this paper
• Imaging the Function of P‐Glycoprotein With Radiotracers: Pharmacokinetics and In Vivo Applications

  2009cited by this paper
• Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding

  2009cited by this paper
• Genuine functions of P-glycoprotein (ABCB1).

  2008cited by this paper
• ABCB1 (MDR1, P-Glycoprotein) C3435T Gene Polymorphism and its Possible Association with Chronic Myeloid Leukemia Prognosis

  2008cited by this paper
• MDR1 C3435T polymorphism in patients with breast cancer.

  2007cited by this paper
• Targeting multidrug resistance in cancer

  2006cited by this paper
• PET kinetic analysis—compartmental model

  2006cited by this paper
• Hepatic Technetium Tc 99m–labeled Sestamibi Elimination Rate and ABCB1 (MDR1) Genotype as Indicators of ABCB1 (P–glycoprotein) Activity in Patients with Cancer

  2005cited by this paper
• The C3435T Polymorphism of MDR1 and Susceptibility to Adult Glioma

  2005cited by this paper
• Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia

  2004cited by this paper
• Differential effects of toremifene on doxorubicin, vinblastine and Tc-99m-sestamibi in P-glycoprotein-expressing breast and head and neck cancer cell lines

  2004cited by this paper
• Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy.

  2003cited by this paper
• Biological Membranes: Structure and Membrane Transport

  2002cited by this paper
• A review of the cost-effectiveness of Tc-99m sestamibi scintimammography in diagnosis of breast cancer in Taiwanese women with indeterminate mammographically dense breast.

  2002cited by this paper
• Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors.

  2002cited by this paper
• 99mTc-sestamibi imaging in the assessment of toremifene as a modulator of multidrug resistance in patients with breast cancer.

  2002cited by this paper
• Genetically determined differences in P-glycoprotein function: implications for disease risk.

  2002cited by this paper
• Prognostic value of (99m)Tc-sestamibi washout in predicting response of locally advanced breast cancer to neoadjuvant chemotherapy.

  2002cited by this paper
• Technetium: Chemistry and Radiopharmaceutical Applications.

  2001cited by this paper
• Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients.

  2001cited by this paper
• Frequency of single nucleotide polymorphisms in the P‐glycoprotein drug transporter MDR1 gene in white subjects

  2001cited by this paper
• The clinical value of 18F-FDG detection with a dual-head coincidence camera: a review

  2001cited by this paper
• Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer.

  1998cited by this paper
• Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients.

  1997cited by this paper
• Decision analysis: MIBI imaging of nonpalpable breast abnormalities.

  1997cited by this paper
• Detection of in vivo P-glycoprotein inhibition by PSC 833 using Tc-99m sestamibi.

  1997cited by this paper
• Technetium-99m-sestamibi cellular uptake: passive or secondary active transport?

  1997cited by this paper
• Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases

  1996cited by this paper
• Double phase parathyroid technetium-99m-MIBI scintigraphy to identify functional autonomy in secondary hyperparathyroidism.

  1996cited by this paper
• Prognostic relevance of P-glycoprotein expression in breast cancer.

  1995cited by this paper
• Mitochondrial localization and characterization of 99Tc-SESTAMIBI in heart cells by electron probe X-ray microanalysis and 99Tc-NMR spectroscopy.

  1994cited by this paper
• Microprobe analysis of Tc-MIBI in heart cells: calculation of mitochondrial membrane potential.

  1993cited by this paper
• Clinical applications of positron‐emission tomography in cancer

  1993cited by this paper
• Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.

  1993influential reference
• Enhancement by tetraphenylborate of technetium-99m-MIBI uptake kinetics and accumulation in cultured chick myocardial cells.

  1991cited by this paper
• Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence.

  1990cited by this paper
• Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

  1987cited by this paper
• METABOLIC TRAPPING AS A PRINCIPLE OF RADIO-PHARMACEUTICAL DESIGN: SOME FACTORS RESPONSIBLE FOR THE BIODISTRIBUTION OF 18F-2-DEOXY-2-FLUORO-D-GLUCOSE

  1979cited by this paper
• Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose.

  1978cited by this paper

• Mathematical modeling of concentration/ time-activity profiles of radiotracers in positron emission tomography

  2022cites this paper
• A Mathematical Model On The Dynamics Of Radioactive Tracer Flow In PET Scan (cid:3)

  2022cites this paper
• The diagnostic value of dual-phase SPECT/CT scintigraphy based on transport kinetics of 99mTc-sestamibi confirmed with histopathological findings in patients with secondary hyperparathyroidism - practical consideration.

  2020cites this paper
• Technetium-99m metastable radiochemistry for pharmaceutical applications: old chemistry for new products

  2019cites this paper
• Estimation of Parameters of Parathyroid Glands Using Particle Swarm Optimization and Multivariate Generalized Gaussian Function Mixture

  2019cites this paper
• Mechanisms of Uptake of Common Radiopharmaceuticals RadioGraphics Fundamentals | Online Presentation.

  2018cites this paper